Last updated: October 8, 2024
Sponsor: University of Oklahoma
Overall Status: Active - Recruiting
Phase
2
Condition
Cerebral Ischemia
Memory Problems
Alzheimer's Disease
Treatment
Transcranial Dirrect Current Stimulation
Clinical Study ID
NCT06516588
17265
Ages 18-99 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- ischemic stroke participants in sub-acute phase (at least 10 days after stroke eventor discharge and under 5 months post-event) with cognitive dysfunction (MoCA <26);
Exclusion
Exclusion Criteria:
clinically significant or unstable medical or psychiatric condition;
diagnosis of severe depression;
history of relevant neurological diagnosis (e.g., epilepsy);
previous neurosurgical procedure with craniectomy;
contraindications to tDCS (implanted brain medical devices);
severe visual impairment, hearing impairment, aphasia, neglect or dementia.
Study Design
Total Participants: 80
Treatment Group(s): 1
Primary Treatment: Transcranial Dirrect Current Stimulation
Phase: 2
Study Start date:
September 30, 2024
Estimated Completion Date:
June 30, 2027
Study Description
Connect with a study center
University of Oklahoma
Oklahoma City, Oklahoma 73117
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.